Johnson & Johnson

(File photo credit: PAUL J. RICHARDS/AFP/Getty Images)

AbbVie To Buy Leukemia Drugmaker Pharmacyclics For $21B

AbbVie — based in North Chicago — said late Wednesday that it will pay $261.25 a share for Pharmacyclics, which makes Imbruvica, a drug approved to treat three different types of blood cancers. That represents a premium of about 21 percent to the closing price of Pharmacyclics shares on Tuesday.


Gavel File Photo (Photo by Chip Somodevilla/Getty Images)

Chicago Man Blew Whistle On Johnson & Johnson

Johnson & Johnson has agreed to pay more than $2 billion to settle some serious criminal and civil charges with the federal government. CBS 2’s Jim Williams reports.



Lawsuit: Tylenol Was To Blame For Baby’s Death

The makers of Tylenol are facing a new lawsuit filed by an Illinois family on an old recall.

CBS Chicago–04/17/2012

Discarded Tylenol

Self-Published Book Claims Conspiracy In Tylenol Poisonings

New revelations have surfaced about the origin of the infamous Tylenol poisonings nearly three decades ago.

CBS Chicago–09/26/2011

Stethoscope (Photo Illustration by Andreas Rentz/Getty Images)

Study: Drug, Device Help Treat Heart Failure

There’s good news for millions of people with mild or moderate heart failure.